Phase 3 FINCH 1 and FINCH 3 Data of Filgotinib in Rheumatoid Arthritis to Be Featured in Opening Plenary and Late Breaker Sessions Gilead Sciences Inc. NASDAQ GILD and Galapagos NV Euronext & NASDAQ GLPG today announced...
↧